Offering close to 2.5 times oversubscribed versus the initial minimum target OSE IMMUNOTHERAPEUTICS (Euronext – FR0012127173 – OSE or the “Company”), an... View Article
Author Archives for Adeline Chauvigné
Ose Immunotherapeutics announces a successful capital increase of €18.6M by private placement
1 July 2025Offering close to 2.5 times oversubscribed versus the initial minimum target OSE IMMUNOTHERAPEUTICS (Euronext – FR0012127173 – OSE or the “Company”), an... View Article
New member | Ceva Biovac
Based in Beaucouzé (Maine-et-Loire), Ceva Biovac is a subsidiary of CEVA Santé Animale, 5th laboratory in the world and 1st... View Article
New member | Ceva Biovac
1 July 2025Based in Beaucouzé (Maine-et-Loire), Ceva Biovac is a subsidiary of CEVA Santé Animale, 5th laboratory in the world and 1st... View Article
XAV-19: validation of the first dose of anti-Covid treatment of XENOTHERA and continuation of the POLYCOR clinical trial
A new step for XENOTHERA and the CHU de Nantes in the daily fight against Covid-19 ! The POLYCOR clinical... View Article
XAV-19: validation of the first dose of anti-Covid treatment of XENOTHERA and continuation of the POLYCOR clinical trial
1 July 2025A new step for XENOTHERA and the CHU de Nantes in the daily fight against Covid-19 ! The POLYCOR clinical... View Article
GlioCure and Institut Curie announce partnership for the treatment of solid cancers, with the support of Findmed
Institut Curie/Carnot Curie Cancer and GlioCure announce the launch of a collaborative research project with the support of FINDMED, as... View Article
GlioCure and Institut Curie announce partnership for the treatment of solid cancers, with the support of Findmed
1 July 2025Institut Curie/Carnot Curie Cancer and GlioCure announce the launch of a collaborative research project with the support of FINDMED, as... View Article
OSE Immunotherapeutics Provides COVID-19 Vaccine Update on CoVepiT, its Multi-Target and Long-Lasting Vaccine Candidate
• Primary Objective Achieved in Human Ex Vivo Study • New Coronavirus Mutated Variants Strengthen the Multi-Epitope T Lymphocytes Vaccine... View Article
OSE Immunotherapeutics Provides COVID-19 Vaccine Update on CoVepiT, its Multi-Target and Long-Lasting Vaccine Candidate
1 July 2025• Primary Objective Achieved in Human Ex Vivo Study • New Coronavirus Mutated Variants Strengthen the Multi-Epitope T Lymphocytes Vaccine... View Article
New member | Inovalys
Inovalys is a public laboratory which operates over a geographical area covering the Pays de la Loire, the Centre of... View Article
New member | Inovalys
1 July 2025Inovalys is a public laboratory which operates over a geographical area covering the Pays de la Loire, the Centre of... View Article
OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy Triggering Resolution of Chronic Inflammation
OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) presented preclinical efficacy data for novel agonist monoclonal antibody therapy, OSE-230, at the 2020... View Article
OSE Immunotherapeutics Presents OSE-230 as a Novel Agonist Monoclonal Antibody Therapy Triggering Resolution of Chronic Inflammation
1 July 2025OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) presented preclinical efficacy data for novel agonist monoclonal antibody therapy, OSE-230, at the 2020... View Article
New member | KetoM+ Medical Food
KetoM+: Facilitate the access for therapeutic metabolic diets KetoM+ develops a new generation of ketogenic products adapted to therapeutic diets.... View Article
New member | KetoM+ Medical Food
1 July 2025KetoM+: Facilitate the access for therapeutic metabolic diets KetoM+ develops a new generation of ketogenic products adapted to therapeutic diets.... View Article
Biofortis and ProDigest announce an agreement for a global collaboration in the field of gastrointestinal research
ProDigest, specialists in intestinal research and Biofortis, Mérieux NutriSciences’ Contract Research Organization serving innovation in nutrition, health, and microbiota studies,... View Article
Biofortis and ProDigest announce an agreement for a global collaboration in the field of gastrointestinal research
1 July 2025ProDigest, specialists in intestinal research and Biofortis, Mérieux NutriSciences’ Contract Research Organization serving innovation in nutrition, health, and microbiota studies,... View Article
Owkin and Nantes University Hospital (CHU Nantes) to Advance Cancer Research with Artificial Intelligence
Owkin, a startup that deploys AI and Federated Learning technologies to augment medical research and enable scientific discoveries, announces a... View Article
Owkin and Nantes University Hospital (CHU Nantes) to Advance Cancer Research with Artificial Intelligence
1 July 2025Owkin, a startup that deploys AI and Federated Learning technologies to augment medical research and enable scientific discoveries, announces a... View Article